Morgan Stanley
IPSC icon

Morgan Stanley’s Century Therapeutics IPSC Stock Holding History

Morgan Stanley’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.2K Buy
38,454
+12,205
+46% +$27.9K ﹤0.01% 6279
2026
Q1 		$59.3K Buy
+26,249
New +$55.2K ﹤0.01% 6355
2025
Q4 		– Sell
-118
Closed -$59 – 8339
2025
Q3 		$59 Sell
118
-11,222
-99% -$6.05K ﹤0.01% 7792
2025
Q2 		$6.34K Sell
11,340
-46,127
-80% -$24.7K ﹤0.01% 6968
2025
Q1 		$27.4K Sell
57,467
-213,558
-79% -$160K ﹤0.01% 6456
2024
Q4 		$274K Sell
271,025
-1,998,197
-88% -$2.72M ﹤0.01% 5670
2024
Q3 		$3.88M Buy
2,269,222
+2,040,609
+893% +$4M ﹤0.01% 4160
2024
Q2 		$583K Buy
228,613
+14,233
+7% +$45K ﹤0.01% 5223
2024
Q1 		$896K Sell
214,380
-65,548
-23% -$277K ﹤0.01% 5022
2023
Q4 		$929K Sell
279,928
-44,580
-14% -$81.2K ﹤0.01% 4962
2023
Q3 		$649K Buy
324,508
+137,339
+73% +$365K ﹤0.01% 5044
2023
Q2 		$591K Buy
187,169
+134,833
+258% +$435K ﹤0.01% 5126
2023
Q1 		$182K Buy
52,336
+28,249
+117% +$124K ﹤0.01% 5744
2022
Q4 		$124K Buy
24,087
+5,675
+31% +$53.6K ﹤0.01% 5887
2022
Q3 		$182K Sell
18,412
-392,373
-96% -$4.13M ﹤0.01% 5768
2022
Q2 		$3.45M Buy
410,785
+27,283
+7% +$268K ﹤0.01% 4092
2022
Q1 		$4.83M Sell
383,502
-62,914
-14% -$834K ﹤0.01% 3727
2021
Q4 		$7.08M Buy
446,416
+114,547
+35% +$2.15M ﹤0.01% 3346
2021
Q3 		$8.35M Sell
331,869
-4,354
-1% -$118K ﹤0.01% 3104
2021
Q2 		$9.87M Buy
+336,223
New +$8.53M ﹤0.01% 2998

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Morgan Stanley's IPSC Position: Q2 2026 in Review

Morgan Stanley increased its Century Therapeutics (IPSC) stake by 46% in Q2 2026, buying an estimated $27.9K and bringing the position to 38,454 shares worth $94.2K. The position accounts for ﹤0.01% of the portfolio, ranked #6279.

Morgan Stanley first reported a position in IPSC in Q2 2021 and has held it in 20 quarters since. The position peaked at $9.87M in Q2 2021. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Morgan Stanley held 38,454 shares of Century Therapeutics worth $94.2K as of Q2 2026.
  • Morgan Stanley bought 12,205 Century Therapeutics shares in Q2 2026, an estimated $27.9K.
  • Century Therapeutics made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6279 holding.
  • Morgan Stanley first reported a position in Century Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Morgan Stanley's Century Therapeutics position peaked at $9.87M in Q2 2021.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.